Published in Drug Discov Today Technol on December 01, 2013
Alternative modulation of protein-protein interactions by small molecules. Curr Opin Biotechnol (2015) 0.79
Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold. Org Biomol Chem (2015) 0.78
Between a rock and a hard place? Nat Chem Biol (2006) 1.77
Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure (2008) 1.39
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A. Antimicrob Agents Chemother (2009) 1.21
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem (2013) 1.07
Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci (2010) 1.02
Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry (2006) 0.99
Identification of potent and selective amidobipyridyl inhibitors of protein kinase D. J Med Chem (2010) 0.98
Identification of orally available naphthyridine protein kinase D inhibitors. J Med Chem (2010) 0.94
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery. Bioorg Med Chem Lett (2011) 0.91
New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors. Curr Top Med Chem (2005) 0.91
A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem (2004) 0.90
Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism. ACS Chem Biol (2011) 0.90
3,5-diarylazoles as novel and selective inhibitors of protein kinase D. Bioorg Med Chem Lett (2011) 0.88
Synapto-depressive effects of amyloid beta require PICK1. Eur J Neurosci (2014) 0.85
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors. Bioorg Med Chem Lett (2012) 0.81
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists. J Med Chem (2004) 0.81
Resolution of disulfide heterogeneity in Nogo receptor I fusion proteins by molecular engineering. Biotechnol Appl Biochem (2010) 0.81
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer. Bioorg Med Chem Lett (2007) 0.79
Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists. Bioorg Med Chem Lett (2004) 0.79
Disulfide structure of the leucine-rich repeat C-terminal cap and C-terminal stalk region of Nogo-66 receptor. Biochemistry (2005) 0.79
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. J Med Chem (2004) 0.78
Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles. Bioorg Med Chem Lett (2004) 0.78
Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors. Bioorg Med Chem Lett (2008) 0.78
Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs. Bioorg Med Chem Lett (2010) 0.78
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. Bioorg Med Chem Lett (2005) 0.78
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. J Med Chem (2005) 0.78
Agonist-induced transitions of the acetylcholine receptor. Ann N Y Acad Sci (2003) 0.77
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1. Bioorg Med Chem Lett (2012) 0.77
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists. Bioorg Med Chem Lett (2005) 0.77
Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett (2005) 0.76
Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach. Bioorg Med Chem Lett (2011) 0.76
Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors. Bioorg Med Chem Lett (2008) 0.75
The statistics of virtual screening and lead optimization. J Comput Aided Mol Des (2015) 0.75
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I). Bioorg Med Chem Lett (2011) 0.75
Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulations. Curr Pharm Des (2013) 0.75